Mader Thomas H, Gibson C Robert, Schmid Josef F, Lipsky William, Sargsyan Ashot E, Garcia Kathleen, Williams Jeffrey N
Aerosp Med Hum Perform. 2018 Jan 1;89(1):63-65. doi: 10.3357/AMHP.4986.2018.
The purpose of this paper is to report the first use of an intraocular lens (IOL) in an astronaut during long duration spaceflight (LDSF). An astronaut developed a unilateral cataract and underwent phacoemulsification with insertion of an acrylic IOL. Approximately 15 mo later he flew on a Soyuz spacecraft to the International Space Station (ISS), where he successfully completed a 6-mo mission.
Ocular examination, including ultrasound (US), was performed before, during, and after his mission and he was questioned regarding visual changes during each portion of his flight.
We documented no change in IOL position during his space mission. This astronaut reported excellent and stable vision during liftoff, entry into microgravity (MG), 6 mo on the ISS, descent, and landing. Our results suggest that modern IOLs are stable, effective, and well tolerated during LDSF.Mader TH, Gibson CR, Schmid JF, Lipsky W, Sargsyan AE, Garcia K, Williams JN. Intraocular lens use in an astronaut during long duration spaceflight. Aerosp Med Hum Perform. 2018; 89(1):63-65.
本文旨在报道在长期太空飞行（LDSF）期间首次在一名宇航员身上使用人工晶状体（IOL）的情况。一名宇航员患上了单侧白内障，并接受了超声乳化术并植入了丙烯酸人工晶状体。大约15个月后，他乘坐联盟号宇宙飞船前往国际空间站（ISS），并在那里成功完成了为期6个月的任务。
在他执行任务前、任务期间和任务后都进行了眼部检查，包括超声检查（US），并询问了他在飞行各阶段的视力变化情况。
我们记录到在他的太空任务期间人工晶状体位置没有变化。这位宇航员报告称在升空、进入微重力状态（MG）、在国际空间站停留6个月、下降和着陆期间视力良好且稳定。我们的结果表明，现代人工晶状体在长期太空飞行期间是稳定、有效的，并且耐受性良好。
马德 TH、吉布森 CR、施密德 JF、利普斯基 W、萨尔格扬 AE、加西亚 K、威廉姆斯 JN。长期太空飞行期间一名宇航员使用人工晶状体的情况。航空航天医学与人类表现。2018；89(1):63 - 65。
